Published in J Clin Invest on May 01, 1994
TGF-beta1 increases proliferation of airway smooth muscle cells by phosphorylation of map kinases. Respir Res (2006) 1.26
Vascular hypertrophy in experimental diabetes. Role of advanced glycation end products. J Clin Invest (1997) 1.12
Essential hypertension and risk of nephropathy: a reappraisal. Curr Opin Nephrol Hypertens (2010) 1.04
Mechanisms simultaneously regulate smooth muscle proliferation and differentiation. J Biomed Res (2013) 0.96
RUNX1 is essential for mesenchymal stem cell proliferation and myofibroblast differentiation. Proc Natl Acad Sci U S A (2014) 0.95
Macrophage LRP1 suppresses neo-intima formation during vascular remodeling by modulating the TGF-β signaling pathway. PLoS One (2011) 0.89
Cell division cycle 7 is a novel regulator of transforming growth factor-β-induced smooth muscle cell differentiation. J Biol Chem (2012) 0.89
Cold ischemia induces isograft arteriopathy, but does not augment allograft arteriopathy in non-immunosuppressed hosts. Am J Pathol (2002) 0.87
Regulation of the atheroma-enriched protein, SPRR3, in vascular smooth muscle cells through cyclic strain is dependent on integrin alpha1beta1/collagen interaction. Am J Pathol (2008) 0.82
Transforming Growth Factor-β: Master Regulator of the Respiratory System in Health and Disease. Am J Respir Cell Mol Biol (2016) 0.81
TGF-beta1 does not induce senescence of multipotent mesenchymal stromal cells and has similar effects in early and late passages. PLoS One (2013) 0.79
Cell division cycle 7 mediates transforming growth factor-β-induced smooth muscle maturation through activation of myocardin gene transcription. J Biol Chem (2013) 0.77
Baicalin inhibits PDGF-induced proliferation and migration of airway smooth muscle cells. Int J Clin Exp Med (2015) 0.77
Perivascular delivery of blebbistatin reduces neointimal hyperplasia after carotid injury in the mouse. J Pharmacol Exp Ther (2010) 0.76
Macromolecular approaches to prevent thrombosis and intimal hyperplasia following percutaneous coronary intervention. Biomacromolecules (2014) 0.75
Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem (1986) 10.00
A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation. J Cell Biol (1986) 6.83
Expression and secretion of type beta transforming growth factor by activated human macrophages. Proc Natl Acad Sci U S A (1987) 6.76
Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science (1991) 4.27
Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells. J Cell Biol (1986) 3.77
Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res (1988) 3.71
Two different subunits associate to create isoform-specific platelet-derived growth factor receptors. J Biol Chem (1989) 3.33
Cultured endothelial cells produce a platelet-derived growth factor-like protein. Proc Natl Acad Sci U S A (1983) 3.29
Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta. Science (1993) 3.28
TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell (1990) 2.82
Production of transforming growth factor beta 1 during repair of arterial injury. J Clin Invest (1991) 2.70
Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science (1989) 2.46
Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res (1991) 2.39
Role of basic fibroblast growth factor in vascular lesion formation. Circ Res (1991) 2.38
Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-beta activities. Science (1993) 2.35
PDGF ligand and receptor gene expression during repair of arterial injury. J Cell Biol (1990) 2.26
Cloning of a type I TGF-beta receptor and its effect on TGF-beta binding to the type II receptor. Science (1993) 2.20
Culture of quiescent arterial smooth muscle cells in a defined serum-free medium. J Cell Physiol (1983) 2.03
Transforming growth factor-beta-induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells. J Cell Biol (1988) 1.73
Responsiveness to transforming growth factor-beta (TGF-beta) restored by genetic complementation between cells defective in TGF-beta receptors I and II. J Biol Chem (1991) 1.71
Beta-type transforming growth factor specifies organizational behavior in vascular smooth muscle cell cultures. J Cell Biol (1987) 1.48
Role of PDGF-A expression in the control of vascular smooth muscle cell growth by transforming growth factor-beta. J Cell Biol (1990) 1.35
Differential modulation of vascular cell integrin and extracellular matrix expression in vitro by TGF-beta 1 correlates with reciprocal effects on cell migration. J Cell Physiol (1992) 1.24
Angiotensin II-induced mitogenesis of spontaneously hypertensive rat-derived cultured smooth muscle cells is dependent on autocrine production of transforming growth factor-beta. Circ Res (1992) 1.21
Vascular smooth muscle cells express distinct transforming growth factor-beta receptor phenotypes as a function of cell density in culture. J Biol Chem (1989) 1.15
Regulation of vascular smooth muscle cell integrin expression by transforming growth factor beta1 and by platelet-derived growth factor-BB. J Cell Physiol (1992) 1.07
Platelet-derived growth factor and transforming growth factor-beta regulate plasminogen activator inhibitor-1 synthesis in vascular smooth muscle cells. J Biol Chem (1991) 0.99
Transforming growth factor beta 1 is a powerful modulator of platelet-derived growth factor action in vascular smooth muscle cells. J Cell Physiol (1992) 0.96
Conservation in sequence and affinity of human and rodent PDGF ligands and receptors. Biochim Biophys Acta (1993) 0.89
Transforming growth factor beta 1-mediated inhibition of smooth muscle cell proliferation is associated with a late G1 cell cycle arrest. J Cell Physiol (1993) 0.86
Thrombin-induced mitogenesis of vascular SMC is partially mediated by autocrine production of PDGF-AA. Am J Physiol (1993) 0.85
Inhibitory effect of transforming growth factor-beta on epidermal growth factor-induced proliferation of cultured rat aortic smooth muscle cells. Biochem Biophys Res Commun (1988) 0.80
TGF-beta 1 potentiates growth factor-stimulated proliferation of vascular smooth muscle cells in genetic hypertension. Am J Physiol (1992) 0.80
ANG II- or AVP-induced increases in protein synthesis are not dependent on autocrine secretion of PDGF-AA. Am J Physiol (1993) 0.77
Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res (1988) 3.71
Expression of smooth muscle-specific alpha-isoactin in cultured vascular smooth muscle cells: relationship between growth and cytodifferentiation. J Cell Biol (1986) 3.00
L-type voltage-gated Ca2+ channels modulate expression of smooth muscle differentiation marker genes via a rho kinase/myocardin/SRF-dependent mechanism. Circ Res (2004) 2.55
Positive- and negative-acting Kruppel-like transcription factors bind a transforming growth factor beta control element required for expression of the smooth muscle cell differentiation marker SM22alpha in vivo. J Biol Chem (2000) 2.54
Molecular mechanisms of decreased smooth muscle differentiation marker expression after vascular injury. J Clin Invest (2000) 2.33
Development of a smooth muscle-targeted cre recombinase mouse reveals novel insights regarding smooth muscle myosin heavy chain promoter regulation. Circ Res (2000) 2.30
Smooth muscle differentiation marker gene expression is regulated by RhoA-mediated actin polymerization. J Biol Chem (2001) 2.28
A transforming growth factor beta (TGFbeta) control element drives TGFbeta-induced stimulation of smooth muscle alpha-actin gene expression in concert with two CArG elements. J Biol Chem (1997) 2.26
Regulation of smooth muscle alpha-actin expression in vivo is dependent on CArG elements within the 5' and first intron promoter regions. Circ Res (1999) 2.20
Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. J Clin Invest (1993) 2.11
A G/C element mediates repression of the SM22alpha promoter within phenotypically modulated smooth muscle cells in experimental atherosclerosis. Circ Res (2004) 1.76
Expression of smooth muscle and nonmuscle myosin heavy chains in cultured vascular smooth muscle cells. J Biol Chem (1986) 1.74
CArG elements control smooth muscle subtype-specific expression of smooth muscle myosin in vivo. J Clin Invest (2001) 1.69
LPP expression during in vitro smooth muscle differentiation and stent-induced vascular injury. Circ Res (2006) 1.65
Alterations in vascular smooth muscle mass in the spontaneously hypertensive rat. Role of cellular hypertrophy, hyperploidy, and hyperplasia. Circ Res (1982) 1.64
Smooth muscle-specific expression of the smooth muscle myosin heavy chain gene in transgenic mice requires 5'-flanking and first intronic DNA sequence. Circ Res (1998) 1.55
Smooth muscle cell hypertrophy versus hyperplasia in hypertension. Proc Natl Acad Sci U S A (1981) 1.51
Selective expression of an endogenous inhibitor of FAK regulates proliferation and migration of vascular smooth muscle cells. Mol Cell Biol (2001) 1.49
Interaction of CArG elements and a GC-rich repressor element in transcriptional regulation of the smooth muscle myosin heavy chain gene in vascular smooth muscle cells. J Biol Chem (1997) 1.36
Similarities and differences in smooth muscle alpha-actin induction by TGF-beta in smooth muscle versus non-smooth muscle cells. Arterioscler Thromb Vasc Biol (1999) 1.34
Development of the aortic vessel wall as defined by vascular smooth muscle and extracellular matrix markers. Dev Biol (1996) 1.34
The smooth muscle alpha-actin gene promoter is differentially regulated in smooth muscle versus non-smooth muscle cells. J Biol Chem (1995) 1.29
Platelet-derived growth factor-BB-induced suppression of smooth muscle cell differentiation. Circ Res (1992) 1.27
Smooth muscle alpha-actin CArG elements coordinate formation of a smooth muscle cell-selective, serum response factor-containing activation complex. Circ Res (2000) 1.26
Vascular smooth muscle cell hypertrophy and hyperploidy in the Goldblatt hypertensive rat. Circ Res (1983) 1.23
Smooth muscle of telokin-deficient mice exhibits increased sensitivity to Ca2+ and decreased cGMP-induced relaxation. Proc Natl Acad Sci U S A (2006) 1.22
Angiotensin II-induced mitogenesis of spontaneously hypertensive rat-derived cultured smooth muscle cells is dependent on autocrine production of transforming growth factor-beta. Circ Res (1992) 1.21
Reversible permeabilization. A novel technique for the intracellular introduction of antisense oligodeoxynucleotides into intact smooth muscle. Circ Res (1995) 1.20
Elements of the smooth muscle alpha-actin promoter required in cis for transcriptional activation in smooth muscle. Evidence for cell type-specific regulation. J Biol Chem (1992) 1.20
Expression of the smooth muscle myosin heavy chain gene is regulated by a negative-acting GC-rich element located between two positive-acting serum response factor-binding elements. J Biol Chem (1997) 1.16
Angiotensin II-induced stimulation of smooth muscle alpha-actin expression by serum response factor and the homeodomain transcription factor MHox. Circ Res (1997) 1.16
Myosin light chain kinase knockout. J Muscle Res Cell Motil (2004) 1.16
Platelet-derived growth factor regulates actin isoform expression and growth state in cultured rat aortic smooth muscle cells. J Cell Physiol (1990) 1.14
Cell cycle versus density dependence of smooth muscle alpha actin expression in cultured rat aortic smooth muscle cells. J Cell Biol (1988) 1.13
Platelet-derived growth factor-induced destabilization of smooth muscle alpha-actin mRNA. J Cell Physiol (1990) 1.09
Immunohistochemical identification of arteriolar development using markers of smooth muscle differentiation. Evidence that capillary arterialization proceeds from terminal arterioles. Circ Res (1994) 1.07
Influence of blood pressure on development of aortic medial smooth muscle hypertrophy in spontaneously hypertensive rats. Hypertension (1987) 1.06
Developmental changes in isoactin expression in rat aortic smooth muscle cells in vivo. Relationship between growth and cytodifferentiation. J Biol Chem (1986) 1.06
Hyperplastic growth response of vascular smooth muscle cells following induction of acute hypertension in rats by aortic coarctation. Circ Res (1985) 1.04
Phosphorylation of the rRNA transcription factor upstream binding factor promotes its association with TATA binding protein. Proc Natl Acad Sci U S A (1998) 1.02
Conditional mouse models to study developmental and pathophysiological gene function in muscle. Handb Exp Pharmacol (2007) 1.00
Differential effects of antihypertensive drug therapy on vascular smooth muscle cell hypertrophy, hyperploidy, and hyperplasia in the spontaneously hypertensive rat. Circ Res (1985) 1.00
Differential effect of platelet-derived growth factor- versus serum-induced growth on smooth muscle alpha-actin and nonmuscle beta-actin mRNA expression in cultured rat aortic smooth muscle cells. J Biol Chem (1989) 0.99
The smooth muscle myosin heavy chain gene exhibits smooth muscle subtype-selective modular regulation in vivo. J Biol Chem (2001) 0.99
Evidence for endothelium-derived relaxing factor in cultured cells. Hypertension (1985) 0.98
Angiotensin II-induced hypertrophy of rat vascular smooth muscle is associated with increased 18 S rRNA synthesis and phosphorylation of the rRNA transcription factor, upstream binding factor. J Biol Chem (1995) 0.96
Thrombin and vascular smooth muscle cell proliferation: implications for atherosclerosis and restenosis. Semin Thromb Hemost (1996) 0.95
Mechanism of enlargement of major cerebral collateral arteries in rabbits. Stroke (1991) 0.92
All-trans-retinoic acid limits restenosis after balloon angioplasty in the focally atherosclerotic rabbit : a favorable effect on vessel remodeling. Arterioscler Thromb Vasc Biol (2000) 0.91
Polyploid nuclei in human artery wall smooth muscle cells. Proc Natl Acad Sci U S A (1983) 0.87
Two MCAT elements of the SM alpha-actin promoter function differentially in SM vs. non-SM cells. Am J Physiol (1998) 0.87
Activated alpha 2-macroglobulin and transforming growth factor-beta 1 induce a synergistic smooth muscle cell proliferative response. J Biol Chem (1993) 0.87
A retinoic acid-induced clonal cell line derived from multipotential P19 embryonal carcinoma cells expresses smooth muscle characteristics. Circ Res (1995) 0.86
alpha-Thrombin induces transforming growth factor-beta1 mRNA and protein in cultured vascular smooth muscle cells via a proteolytically activated receptor. J Vasc Res (1997) 0.86
Activated alpha 2-macroglobulin promotes mitogenesis in rat vascular smooth muscle cells by a mechanism that is independent of growth-factor-carrier activity. Eur J Biochem (1995) 0.86
Thrombin-induced mitogenesis of vascular SMC is partially mediated by autocrine production of PDGF-AA. Am J Physiol (1993) 0.85
Thrombin-induced mitogenesis in cultured aortic smooth muscle cells requires prolonged thrombin exposure. Am J Physiol (1995) 0.84
Characterization of an E-box-dependent cis element in the smooth muscle alpha-actin promoter. Arterioscler Thromb Vasc Biol (1999) 0.84
Role of mechanical strain in regulation of differentiation of vascular smooth muscle cells. Circ Res (1996) 0.83
Pathophysiology of smooth muscle in hypertension. Can J Physiol Pharmacol (1995) 0.82
Differential activation of the SMalphaA promoter in smooth vs. skeletal muscle cells by bHLH factors. Am J Physiol (1999) 0.81
Early plus delayed hirudin reduces restenosis in the atherosclerotic rabbit more than early administration alone: potential implications for dosing of antithrombin agents. Circulation (1998) 0.81
Predictors of luminal narrowing by neointima after angioplasty in atherosclerotic rabbits. Cardiovasc Res (1997) 0.80
Endothelial cell-conditioned medium downregulates smooth muscle contractile protein expression. Am J Physiol (1997) 0.80
Angiotensin II stimulates increased protein synthesis, not increased DNA synthesis, in intact rat aortic segments, in vitro. J Vasc Res (1993) 0.79
Relationship between inhibition of aortic histamine formation, aortic albumin permeability and atherosclerosis. Atherosclerosis (1979) 0.78
Nuclear proteins bind a cis-acting element in the smooth muscle alpha-actin promoter. Am J Physiol (1995) 0.78
Expression of myosin regulatory light-chain isoforms and regulation of phosphorylation in smooth muscle. Am J Physiol (1993) 0.78
Arginine vasopressin-induced hypertrophy of cultured rat aortic smooth muscle cells. Hypertension (1989) 0.77
ANG II- or AVP-induced increases in protein synthesis are not dependent on autocrine secretion of PDGF-AA. Am J Physiol (1993) 0.77
A dynamic model of angiotensin II infusion experiments. J Biomed Eng (1989) 0.76
Ploidy in mesenteric vessels of aged spontaneously hypertensive and Wistar-Kyoto rats. Hypertension (1989) 0.76
Arterial thrombin activity after angioplasty in an atherosclerotic rabbit model: time course and effect of hirudin. Circulation (1996) 0.75
A new single-injury model of balloon angioplasty in cholesterol-fed rabbits: beneficial effect of hirudin and comparison with double-injury model. Lab Invest (1997) 0.75
Local adenovirus-mediated delivery of hirudin in a rabbit arterial injury model. J Vasc Res (1999) 0.75
Effect of thrombin inhibition with desulfatohirudin on early kinetics of cellular proliferation after balloon angioplasty in atherosclerotic rabbits. Circulation (1996) 0.75
Local aortic histamine metabolism and albumin accumulation. Differences between blue and white areas. Arteriosclerosis (1981) 0.75
Fetal expression of muscle-specific isoactins in multiple organs of the Wistar-Kyoto rat. Cell Tissue Res (1987) 0.75